In the present study, we compared gene expression profiles in peripheral blood cells of BRCA1 mutation carriers who belong to high-risk breast cancer families with gene expression profiles of BRCA1 or BRCA2 mutation non-carriers in order to evaluate the possibility of setting up a microarray-based preliminary screening tool. The gene discussed is BRCA2; the disease is breast cancer.